Barrat J, Marpeau L, Demuynck B
Service de Gynécologie Obstétrique, Hôpital Saint-Antoine, Paris.
Rev Fr Gynecol Obstet. 1993 Nov;88(11):544-9.
Breast cancer is generally believed to carry a worse prognosis during pregnancy because of the potential adverse effects of anticancer treatments on the fetus and of pregnancy related hormonal and immunological modifications on the disease. Problems arise both with breast cancers diagnosed during or immediately after pregnancy and with pregnancies occurring in patients previously treated for breast cancer. The incidence of these problems is difficult to estimate, in part because pregnancy-related changes in the breasts obscure clinical and radiological manifestations. Prognosis depends more on patient age than on gestational age at diagnosis. Other prognostic factors include size of the tumor and node involvement. Although the outcome of N+ tumors is more severe during pregnancy, overall the poor prognosis of breast cancer during pregnancy is due to the young age of patients and pregnancy has no bearing on prognosis after adjustment for stage. Similarly, women who become pregnant after being treated for breast cancer do not have worse outcomes. Management is difficult because some treatments cannot be used during pregnancy; the approach is similar to that used in non-pregnant women, although chemotherapy should be given only after 14 or 15 weeks gestational age and irradiation therapy only after delivery.
一般认为,由于抗癌治疗对胎儿的潜在不良影响以及妊娠相关的激素和免疫变化对疾病的影响,乳腺癌在孕期的预后通常较差。孕期或产后立即诊断出的乳腺癌以及先前接受过乳腺癌治疗的患者怀孕都会出现问题。这些问题的发生率难以估计,部分原因是乳房与妊娠相关的变化掩盖了临床和放射学表现。预后更多地取决于患者年龄而非诊断时的孕周。其他预后因素包括肿瘤大小和淋巴结受累情况。尽管N+肿瘤在孕期的结局更为严重,但总体而言,孕期乳腺癌预后不良是由于患者年龄较轻,且调整分期后妊娠与预后无关。同样,乳腺癌治疗后怀孕的女性预后也不会更差。管理困难,因为有些治疗在孕期不能使用;治疗方法与非孕期女性相似,不过化疗应在孕14或15周后进行,放疗仅在分娩后进行。